Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalopathy, Hepatocerebral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01175538
What this trial is testing

Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis

Who this might be right for
Hepatic Encephalopathy
Govind Ballabh Pant Hospital
Large-scale testing (Phase 3)WithdrawnNCT02086825
What this trial is testing

Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure

Who this might be right for
Hepatic Encephalopathy
NYU Langone Health
Not applicableStudy completedNCT04330508
What this trial is testing

Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial

Who this might be right for
Depression in Chronic Hepatitis C
Post Graduate Institute of Medical Education and Research, Chandigarh 385
Testing effectiveness (Phase 2)Active Not RecruitingNCT04862221
What this trial is testing

TReatment for ImmUne Mediated PathopHysiology

Who this might be right for
Acute Liver FailureFulminant Hepatic FailureHepatic Encephalopathy+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 44
Not applicableStudy completedNCT01223768
What this trial is testing

Acetyl-L-Carnitine In Severe Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy (Grade 3 of the West Haven Grading Scale)
University of Catania
Not applicableUnknownNCT02858778
What this trial is testing

Timing of Acute Palliative Care Consultation in Critically Ill Patients

Who this might be right for
Multiple Organ FailureEnd Stage Cardiac FailureEnd Stage Chronic Obstructive Airways Disease+8 more
Wayne State University 120
Not applicableEnrolling By InvitationNCT05433948
What this trial is testing

Diagnosing Minimal Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyLiver Cirrhosis
Esbjerg Hospital - University Hospital of Southern Denmark 550
Post-approval studies (Phase 4)Ended earlyNCT01846663
What this trial is testing

Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Bausch Health Americas, Inc. 6
Not applicableUnknownNCT05140837
What this trial is testing

Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)

Who this might be right for
Hepatic EncephalopathyCirrhosis
Hepatopancreatobiliary Surgery Institute of Gansu Province 10,000
Not applicableStudy completedNCT05033327
What this trial is testing

Feasibility of an App-based Nutrition & Exercise Program in Cirrhosis

Who this might be right for
Cirrhosis, LiverHepatic Encephalopathy
University of Alberta 27
Not applicableActive Not RecruitingNCT07727070
What this trial is testing

Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to Internal Medicine

Who this might be right for
Cirrhoses, LiverPortal Hypertension Related to CirrhosisLiver Stiffness+1 more
Fadoi Foundation, Italy 400
Large-scale testing (Phase 3)WithdrawnNCT04244877
What this trial is testing

Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility

Who this might be right for
Cirrhosis, LiverMinimal Hepatic EncephalopathySmall Intestinal Bacterial Overgrowth+1 more
MetroHealth Medical Center
Not applicableStudy completedNCT01603953
What this trial is testing

Bioelectrical Impedance Vector Analysis in Cirrhotic Patients

Who this might be right for
CirrhosisHepatic Encephalopathy
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 250
Large-scale testing (Phase 3)Active Not RecruitingNCT05071716
What this trial is testing

Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis

Who this might be right for
Hepatic Encephalopathy
Bausch Health Americas, Inc. 524
Not applicableUnknownNCT06374511
What this trial is testing

Prospective Cohort Study of Complications and Outcomes in Cirrhosis

Who this might be right for
Decompensated CirrhosisCMV ReactivationOvert Hepatic Encephalopathy
Nanfang Hospital, Southern Medical University 660
Not applicableStudy completedNCT06248736
What this trial is testing

Description of Lactulose Administration by Balloon Rectal Tube in Severe Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
University Hospital, Grenoble 25
Testing effectiveness (Phase 2)Ended earlyNCT06987968
What this trial is testing

See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyAcute on Chronic Liver Failure (ACLF)Decompensated Cirrhosis
Genfit 3
Early research (Phase 1)Study completedNCT04238416
What this trial is testing

Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF

Who this might be right for
Hepatic EncephalopathyAcute-On-Chronic Liver Failure
Post Graduate Institute of Medical Education and Research, Chandigarh 70
Not applicableEnded earlyNCT02418039
What this trial is testing

High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic Encephalopathy

Who this might be right for
Liver Cirrhosis
Coordinación de Investigación en Salud, Mexico 42
Testing effectiveness (Phase 2)Study completedNCT01966419
What this trial is testing

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Who this might be right for
Acute Episode of Overt Hepatic EncephalopathyHepatic Encephalopathy
Ocera Therapeutics, Inc. 231
Next Page